Search Results - "Balshaw R"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology.

Authors: Smith, G. Malla, A. Williams, R. et al.

Source: Acta Psychiatrica Scandinavica. Supplementum. May2006 Supplement 430, Vol. 113, p4-11. 8p. 4 Charts.

Subjects: Health outcome assessment, Physician practice patterns, Schizophrenia, Psychotherapy patients, Psychiatric clinics, Antipsychotic agents

Geographic Terms: Canada

Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia.

Authors: Williams, R. Kopala, L. Malla, A. et al.

Source: Acta Psychiatrica Scandinavica. Supplementum. May2006 Supplement 430, Vol. 113, p12-21. 10p. 1 Diagram, 12 Charts, 1 Graph.

Subjects: Health outcome assessment, Schizophrenia, Clozapine, Risperidone, Olanzapine, Antipsychotic agents

Geographic Terms: Canada

Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders.

Authors: Malla, A. Williams, R. Kopala, L. et al.

Source: Acta Psychiatrica Scandinavica. Supplementum. May2006 Supplement 430, Vol. 113, p22-28. 7p. 1 Chart.

Subjects: Quality of life, Schizophrenia, Drug efficacy, Age, Gender, Multivariate analysis

Geographic Terms: Canada

Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders.

Authors: Kopala, L. Smith, G. Malla, A. et al.

Source: Acta Psychiatrica Scandinavica. Supplementum. May2006 Supplement 430, Vol. 113, p29-39. 11p. 10 Charts, 2 Graphs.

Subjects: Antipsychotic agents, Schizophrenia, Risk assessment, Risperidone, Olanzapine, Clozapine

Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis.

Authors: Khani-Hanjani, A Lacaille, D Hoar, D et al.

Source: Lancet. 9/2/2000, Vol. 356 Issue 9232, p820-825. 6p. 2 Black and White Photographs, 4 Charts.

Subjects: Genetics of rheumatoid arthritis, Interferons, Genes, Medical genetics

This result is not displayed to guests.
Login for full access.

HLA-DQ de novo donor-specific antibody development and its effect on renal allograft survival.

Authors: Wong, E. Balshaw, R. Gibson, I. et al.

Source: Human Immunology. 2024 Supplement, Vol. 85, pN.PAG-N.PAG. 1p.

This result is not displayed to guests.
Login for full access.

The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.

Authors: Herrmann N Tam DY Balshaw R et al.

Source: Canadian Journal of Psychiatry. Dec2010, Vol. 55 Issue 12, p768-775. 8p.

Two-Hour Post-Dose Cyclosporine Levels in Renal Transplantation in Argentina: A Cost-Effective Strategy for Reducing Acute Rejection

Authors: Balshaw, R. Machnicki, G. Agost Carreño, C. et al.

Source: Transplantation Proceedings. Mar2005, Vol. 37 Issue 2, p871-874. 4p.

Efficiency Lost By Analyzing Counts Rather Than Event Times in Poisson and Overdispersed Poisson Regression Models.

Authors: Dean, C. B. Balshaw, R.

Source: Journal of the American Statistical Association. Dec97, Vol. 92 Issue 440, p1387-1396. 12p. 7 Charts, 2 Graphs.

Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.

Authors: Schultz, K R Nevill, T J Balshaw, R F et al.

Source: Bone Marrow Transplantation. 9/1/2000, Vol. 26 Issue 5, p545. 7p.

PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes: A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom

Authors: Jameson, K. Balshaw, R. Phillips, C. et al.

Source: Value in Health. pA313-A313. 1p.

The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation.

Authors: Dmitrienko, S. Yu, A. Balshaw, R. et al.

Source: Kidney International. Oct2007, Vol. 72 Issue 8, p1014-1022. 9p. 1 Diagram, 4 Charts, 2 Graphs.

Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3.

Authors: Lee, S. S. Sherman, M. Ramji, A. et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2012, Vol. 35 Issue 1, p37-47. 11p. 2 Diagrams, 3 Charts, 1 Graph.

Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin.

Authors: BAIN, V. G. LEE, S. S. PELTEKIAN, K. et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2008, Vol. 28 Issue 1, p43-50. 8p. 2 Charts, 3 Graphs.

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.

Authors: Powis, J. Peltekian, K. M. Lee, S. S. et al.

Source: Journal of Viral Hepatitis. Jan2008, Vol. 15 Issue 1, p52-57. 6p. 3 Charts, 1 Graph.

93: Whole Blood Genomic Biomarkers of Acute Heart Allograft Rejection

Authors: Hollander, Z. Lin, D. Balshaw, R. et al.

Source: Journal of Heart & Lung Transplantation. Feb2008 Supplement, Vol. 27 Issue 2, pS92-S92. 1p.